-
2
-
-
0028827547
-
Residual symptoms after partial remission: An important outcome in depression
-
Paykel ES, Ramana R, Cooper Z, et al. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995;25:1171-1180
-
(1995)
Psychol Med
, vol.25
, pp. 1171-1180
-
-
Paykel, E.S.1
Ramana, R.2
Cooper, Z.3
-
3
-
-
0031777132
-
Three- to 5-year prospective follow-up of outcome in major depression
-
Van London L, Molenaar RP, Goekoop JG, et al. Three- to 5-year prospective follow-up of outcome in major depression. Psychol Med 1998;28:731-735
-
(1998)
Psychol Med
, vol.28
, pp. 731-735
-
-
Van London, L.1
Molenaar, R.P.2
Goekoop, J.G.3
-
4
-
-
0037301753
-
Relapse of major depression after complete and partial remission during a 2-year follow-up
-
Pintor L, Gasto C, Navarro V, et al. Relapse of major depression after complete and partial remission during a 2-year follow-up. J Affect Disord 2003;73:237-244
-
(2003)
J Affect Disord
, vol.73
, pp. 237-244
-
-
Pintor, L.1
Gasto, C.2
Navarro, V.3
-
5
-
-
0026722095
-
Relapse after cognitive behavior therapy of depression: Potential implications for longer courses of treatment
-
Thase ME, Simons AD, McGeary J, et al. Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry 1992;149:1046-1052
-
(1992)
Am J Psychiatry
, vol.149
, pp. 1046-1052
-
-
Thase, M.E.1
Simons, A.D.2
McGeary, J.3
-
6
-
-
0033397229
-
Clinical guidelines for establishing remission in patients with depression and anxiety
-
Ballenger JC. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry 1999;60(suppl 22):29-34
-
(1999)
J Clin Psychiatry
, vol.60
, Issue.SUPPL. 22
, pp. 29-34
-
-
Ballenger, J.C.1
-
7
-
-
0033378990
-
Evolution of remission as the new standard in treatment of depression
-
Nierenberg AA, Wright EC. Evolution of remission as the new standard in treatment of depression. J Clin Psychiatry 1999;60:7-11
-
(1999)
J Clin Psychiatry
, vol.60
, pp. 7-11
-
-
Nierenberg, A.A.1
Wright, E.C.2
-
8
-
-
0032920181
-
Treatment of major depression: Is improvement enough?
-
Ferrier IN. Treatment of major depression: is improvement enough? J Clin Psychiatry 1999;60(suppl 6):10-14
-
(1999)
J Clin Psychiatry
, vol.60
, Issue.SUPPL. 6
, pp. 10-14
-
-
Ferrier, I.N.1
-
9
-
-
0032434360
-
Consensus guidelines in the treatment of major depressive disorder
-
Rush AJ, Crismon ML, Toprac MG, et al. Consensus guidelines in the treatment of major depressive disorder. J Clin Psychiatry 1998;59 (suppl 20):73-84
-
(1998)
J Clin Psychiatry
, vol.59
, Issue.SUPPL. 20
, pp. 73-84
-
-
Rush, A.J.1
Crismon, M.L.2
Toprac, M.G.3
-
10
-
-
21844498979
-
Treating depression to remission
-
Rush A, Trivedi M. Treating depression to remission. Psychiatr Ann 1995;25:704-709
-
(1995)
Psychiatr Ann
, vol.25
, pp. 704-709
-
-
Rush, A.1
Trivedi, M.2
-
11
-
-
0032940230
-
Why settle for silver, when you can go for gold? Response vs recovery as the goal of antidepressant therapy [BRAINSTORMS]
-
Stahl SM. Why settle for silver, when you can go for gold? response vs recovery as the goal of antidepressant therapy [BRAINSTORMS]. J Clin Psychiatry 1999;60:213-214
-
(1999)
J Clin Psychiatry
, vol.60
, pp. 213-214
-
-
Stahl, S.M.1
-
12
-
-
0142043014
-
Evaluating antidepressant therapies: Remission as the optimal outcome
-
Thase ME. Evaluating antidepressant therapies: remission as the optimal outcome. J Clin Psychiatry 2003;64(suppl 13):18-25
-
(2003)
J Clin Psychiatry
, vol.64
, Issue.SUPPL. 13
, pp. 18-25
-
-
Thase, M.E.1
-
13
-
-
0021955819
-
The treatment validity of DSM-III melancholic subtyping
-
Zimmerman M, Coryell W, Pfohl B. The treatment validity of DSM-III melancholic subtyping. Psychiatry Res 1985;16:37-43
-
(1985)
Psychiatry Res
, vol.16
, pp. 37-43
-
-
Zimmerman, M.1
Coryell, W.2
Pfohl, B.3
-
14
-
-
0038507407
-
Past, present, and future directions for defining optimal treatment outcome in depression
-
Keller M. Past, present, and future directions for defining optimal treatment outcome in depression. JAMA 2003;289:3152-3160
-
(2003)
JAMA
, vol.289
, pp. 3152-3160
-
-
Keller, M.1
-
15
-
-
0026006469
-
Conceptualization and rationale for consensus definitions of terms in major depressive disorder
-
Frank E, Prien R, Jarrett R, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry 1991;48:851-855
-
(1991)
Arch Gen Psychiatry
, vol.48
, pp. 851-855
-
-
Frank, E.1
Prien, R.2
Jarrett, R.3
-
16
-
-
14844366998
-
Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high?
-
Zimmerman M, Posternak M, Chelminski I. Is the cutoff to define remission on the Hamilton Rating Scale for Depression too high? J Nerv Ment Dis 2005;193:170-175
-
(2005)
J Nerv Ment Dis
, vol.193
, pp. 170-175
-
-
Zimmerman, M.1
Posternak, M.2
Chelminski, I.3
-
17
-
-
0032171096
-
Major depressive disorder: A prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse
-
Judd LL, Akiskal HS, Maser JD, et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 1998;50:97-108
-
(1998)
J Affect Disord
, vol.50
, pp. 97-108
-
-
Judd, L.L.1
Akiskal, H.S.2
Maser, J.D.3
-
18
-
-
4744351699
-
Using a self-report depression scale to identify remission in depressed outpatients
-
Zimmerman M, Posternak M, Chelminski I. Using a self-report depression scale to identify remission in depressed outpatients. Am J Psychiatry 2004;161:1911-1913
-
(2004)
Am J Psychiatry
, vol.161
, pp. 1911-1913
-
-
Zimmerman, M.1
Posternak, M.2
Chelminski, I.3
-
19
-
-
0003575871
-
-
New York, NY: Biometric Research, New York State Psychiatric Institute
-
First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, version 2.0). New York, NY: Biometric Research, New York State Psychiatric Institute; 1995
-
(1995)
Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, Version 2.0)
-
-
First, M.B.1
Spitzer, R.L.2
Gibbon, M.3
-
20
-
-
21344454122
-
Integrating the assessment methods of researchers in routine clinical practice: The Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project
-
First M, ed. Washington, DC: American Psychiatric Publishing, Inc
-
Zimmerman M. Integrating the assessment methods of researchers in routine clinical practice: The Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project. In: First M, ed. Standardized Evaluation in Clinical Practice, vol 22. Washington, DC: American Psychiatric Publishing, Inc; 2003:29-74
-
(2003)
Standardized Evaluation in Clinical Practice
, vol.22
, pp. 29-74
-
-
Zimmerman, M.1
-
21
-
-
0003412410
-
-
US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health
-
Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
-
(1976)
ECDEU Assessment Manual for Psychopharmacology
, pp. 218-222
-
-
Guy, W.1
-
23
-
-
0036240501
-
Somatic symptoms, depression, and antidepressant treatment
-
Fava M. Somatic symptoms, depression, and antidepressant treatment. J Clin Psychiatry 2002;63:305-307
-
(2002)
J Clin Psychiatry
, vol.63
, pp. 305-307
-
-
Fava, M.1
-
24
-
-
3142542903
-
A review of studies of the Hamilton Depression Rating Scale in healthy controls: Implications for the definition of remission in treatment studies of depression
-
Zimmerman M, Chelminski I, Posternak M. A review of studies of the Hamilton Depression Rating Scale in healthy controls: implications for the definition of remission in treatment studies of depression. J Nerv Ment Dis 2004;192:595-601
-
(2004)
J Nerv Ment Dis
, vol.192
, pp. 595-601
-
-
Zimmerman, M.1
Chelminski, I.2
Posternak, M.3
-
25
-
-
3142554206
-
Implications of using different cutoffs on symptom severity scales to define remission from depression
-
Zimmerman M, Posternak M, Chelminski I. Implications of using different cutoffs on symptom severity scales to define remission from depression. Int Clin Psychopharmacol 2004;19:215-220
-
(2004)
Int Clin Psychopharmacol
, vol.19
, pp. 215-220
-
-
Zimmerman, M.1
Posternak, M.2
Chelminski, I.3
-
26
-
-
0028950421
-
PTSD substance abuse comorbidity and treatment utilization
-
Brown PJ, Recupero PR, Stout R. PTSD substance abuse comorbidity and treatment utilization. Addict Behav 1995;20:251-254
-
(1995)
Addict Behav
, vol.20
, pp. 251-254
-
-
Brown, P.J.1
Recupero, P.R.2
Stout, R.3
|